can glp 1 hurt your kidneys GLP-1 Receptor Agonists and Kidney Protection New Guideline Puts Some at

Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression

[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Zhu C., Li H., Kong X., Wang Y., Sun T., Wang F

There is a unique opportunity for collaboration across specialties to raise awareness around the multiple benefits of GLP-1 RAs and determine the best care pathway to treat patients with PAD. With the ongoing PAD amputation and obesity epidemics, there is an opportunity to establish partnership and open communication between vascular surgeons and weight loss clinics to determine if a patient could benefit from GLP-1 RAs

Future developments affecting us may not be those that we have anticipated